Ras protein expression as a marker for breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Breast cancer is a leading cause of cancer mortality in women globally.
• Current methods lack molecular markers to predict carcinoma in situ progression, necessitating surgery for all cases.
• Identifying prognostic markers is crucial for personalized breast cancer treatment and risk stratification.

Purpose of the Study:

• To identify a novel prognostic marker for breast cancer progression.
• To evaluate the potential of c-Ha-Ras protein expression as a predictive tool.
• To explore non-surgical treatment avenues based on identified markers.

Main Methods:

• Utilized a breast cancer model involving MCF-10F cells exposed to estrogen and alpha particle radiation.
• Developed malignant cell lines (Alpha5 and Tumor2) from the modified MCF-10F cells.
• Analyzed c-Ha-Ras protein expression in cell lines and human breast tissue biopsies (normal, benign, malignant).

Main Results:

• MCF-10F control cells showed negative c-Ha-Ras expression.
• Alpha5 and Tumor2 malignant cell lines exhibited positive c-Ha-Ras expression.
• Malignant breast tissue samples demonstrated strong positive c-Ha-Ras expression.

Conclusions:

• c-Ha-Ras protein expression is significantly associated with breast cancer malignancy and progression.
• This protein may serve as a valuable prognostic marker for breast cancer.
• The findings suggest potential for non-surgical therapeutic strategies in specific patient groups.